• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金合欢素对不同血凝素亚型的甲型流感病毒的抗病毒活性。

Antiviral activity of stachyflin on influenza A viruses of different hemagglutinin subtypes.

机构信息

Department of Disease Control, Hokkaido University, Sapporo, Japan.

出版信息

Virol J. 2013 Apr 16;10:118. doi: 10.1186/1743-422X-10-118.

DOI:10.1186/1743-422X-10-118
PMID:23587221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3648499/
Abstract

BACKGROUND

The hemagglutinin (HA) of influenza viruses is a possible target for antiviral drugs because of its key roles in the initiation of infection. Although it was found that a natural compound, Stachyflin, inhibited the growth of H1 and H2 but not H3 influenza viruses in MDCK cells, inhibitory activity of the compound has not been assessed against H4-H16 influenza viruses and the precise mechanism of inhibition has not been clarified.

METHODS

Inhibitory activity of Stachyflin against H4-H16 influenza viruses, as well as H1-H3 viruses was examined in MDCK cells. To identify factors responsible for the susceptibility of the viruses to this compound, Stachyflin-resistant viruses were selected in MDCK cells and used for computer docking simulation.

RESULTS

It was found that in addition to antiviral activity of Stachyflin against influenza viruses of H1 and H2 subtypes, it inhibited replication of viruses of H5 and H6 subtypes, as well as A(H1N1)pdm09 virus in MDCK cells. Stachyflin also inhibited the virus growth in the lungs of mice infected with A/WSN/1933 (H1N1) and A/chicken/Ibaraki/1/2005 (H5N2). Substitution of amino acid residues was found on the HA2 subunit of Stachyflin-resistant viruses. Docking simulation indicated that D37, K51, T107, and K121 are responsible for construction of the cavity for the binding of the compound. In addition, 3-dimensional structure of the cavity of the HA of Stachyflin-susceptible virus strains was different from that of insusceptible virus strains.

CONCLUSION

Antiviral activity of Stachyflin was found against A(H1N1)pdm09, H5, and H6 viruses, and identified a potential binding pocket for Stachyflin on the HA. The present results should provide us with useful information for the development of HA inhibitors with more effective and broader spectrum.

摘要

背景

流感病毒的血凝素(HA)是抗病毒药物的一个可能靶点,因为它在感染的启动中起着关键作用。虽然已经发现一种天然化合物——Stachyflin 能够抑制 MDCK 细胞中 H1 和 H2 但不能抑制 H3 流感病毒的生长,但该化合物对 H4-H16 流感病毒的抑制活性尚未得到评估,其确切的抑制机制也尚未阐明。

方法

在 MDCK 细胞中检测 Stachyflin 对 H4-H16 流感病毒以及 H1-H3 病毒的抑制活性。为了鉴定导致病毒对该化合物易感性的因素,在 MDCK 细胞中选择 Stachyflin 抗性病毒,并用于计算机对接模拟。

结果

除了对 H1 和 H2 亚型流感病毒的抗病毒活性外,Stachyflin 还抑制了 MDCK 细胞中 H5 和 H6 亚型以及 A(H1N1)pdm09 病毒的复制。Stachyflin 还抑制了感染 A/WSN/1933(H1N1)和 A/chicken/Ibaraki/1/2005(H5N2)的小鼠肺部的病毒生长。在 Stachyflin 抗性病毒中发现 HA2 亚基上的氨基酸残基取代。对接模拟表明,D37、K51、T107 和 K121 负责构建化合物结合的腔。此外,Stachyflin 敏感病毒株的 HA 腔的三维结构与不敏感病毒株的结构不同。

结论

发现 Stachyflin 对 A(H1N1)pdm09、H5 和 H6 病毒具有抗病毒活性,并鉴定出 HA 上 Stachyflin 的潜在结合口袋。本研究结果为开发更有效、更广谱的 HA 抑制剂提供了有用的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c4/3648499/d326f4408ea6/1743-422X-10-118-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c4/3648499/2c8908213349/1743-422X-10-118-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c4/3648499/250ae3b9d6d3/1743-422X-10-118-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c4/3648499/fc3238983d1a/1743-422X-10-118-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c4/3648499/d326f4408ea6/1743-422X-10-118-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c4/3648499/2c8908213349/1743-422X-10-118-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c4/3648499/250ae3b9d6d3/1743-422X-10-118-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c4/3648499/fc3238983d1a/1743-422X-10-118-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c4/3648499/d326f4408ea6/1743-422X-10-118-4.jpg

相似文献

1
Antiviral activity of stachyflin on influenza A viruses of different hemagglutinin subtypes.金合欢素对不同血凝素亚型的甲型流感病毒的抗病毒活性。
Virol J. 2013 Apr 16;10:118. doi: 10.1186/1743-422X-10-118.
2
Identification of a novel HA conformational change inhibitor of human influenza virus.一种新型人甲型流感病毒血凝素构象变化抑制剂的鉴定
Arch Virol. 1999;144(5):865-78. doi: 10.1007/s007050050552.
3
Identification of amino acids of influenza virus HA responsible for resistance to a fusion inhibitor, Stachyflin.鉴定甲型流感病毒血凝素中对融合抑制剂水苏素产生抗性的氨基酸。
Microbiol Immunol. 2000;44(8):677-85. doi: 10.1111/j.1348-0421.2000.tb02549.x.
4
A small molecule compound targeting hemagglutinin inhibits influenza A virus and exhibits broad-spectrum antiviral activity.一种针对血凝素的小分子化合物抑制甲型流感病毒并具有广谱抗病毒活性。
Acta Pharmacol Sin. 2024 Nov;45(11):2380-2393. doi: 10.1038/s41401-024-01331-7. Epub 2024 Jul 10.
5
Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.人源单克隆抗体81.39a可有效中和1组和2组血凝素的新型甲型流感病毒。
J Virol. 2016 Nov 14;90(23):10446-10458. doi: 10.1128/JVI.01284-16. Print 2016 Dec 1.
6
Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains.抗病毒药物耐药聚合酶酸性 I38T 取代对当代甲型流感 A(H1N1)pdm09 和 A(H3N2) 株适应性的影响。
J Infect Dis. 2020 Jan 1;221(1):63-70. doi: 10.1093/infdis/jiz418.
7
A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.Y161F血凝素替换增加了2009年甲型H1N1流感病毒在细胞中的热稳定性并提高了产量。
J Virol. 2018 Jan 2;92(2). doi: 10.1128/JVI.01621-17. Print 2018 Jan 15.
8
and Characterization of Novel Neuraminidase Substitutions in Influenza A(H1N1)pdm09 Virus Identified Using Laninamivir-Mediated Selection.利用拉尼米韦介导的选择对甲型 H1N1pdm09 流感病毒中新型神经氨酸酶取代的鉴定及特征分析
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.01825-18. Print 2019 Mar 15.
9
Hemagglutinins of Avian Influenza Viruses Are Proteolytically Activated by TMPRSS2 in Human and Murine Airway Cells.禽流感病毒的血凝素在人和鼠类的气道细胞中通过 TMPRSS2 被蛋白水解激活。
J Virol. 2021 Sep 27;95(20):e0090621. doi: 10.1128/JVI.00906-21. Epub 2021 Jul 28.
10
Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.来自茯苓的隐孔酸E在体外抑制流感病毒复制。
Antiviral Res. 2017 Jul;143:106-112. doi: 10.1016/j.antiviral.2017.02.010. Epub 2017 Feb 21.

引用本文的文献

1
Novel Anti-Viral Properties of the Herbal Extract of against Influenza A Virus.[某种草药提取物]对甲型流感病毒的新型抗病毒特性 。 需注意,原文中“of the Herbal Extract of”后面缺少具体草药名称,我是按照格式要求直接翻译的,实际应用中需补充完整准确的草药信息。
Viruses. 2024 Mar 28;16(4):523. doi: 10.3390/v16040523.
2
Molecular Modeling of Viral Type I Fusion Proteins: Inhibitors of Influenza Virus Hemagglutinin and the Spike Protein of Coronavirus.病毒 I 型融合蛋白的分子建模:流感病毒血凝素和冠状病毒刺突蛋白的抑制剂。
Viruses. 2023 Mar 31;15(4):902. doi: 10.3390/v15040902.
3
Influenza Virus Entry inhibitors.

本文引用的文献

1
Mechanism of drug resistance of hemagglutinin of influenza virus and potent scaffolds inhibiting its function.流感病毒血凝素的耐药机制及强效抑制其功能的支架分子。
ACS Chem Biol. 2012 Mar 16;7(3):552-62. doi: 10.1021/cb200332k. Epub 2012 Jan 13.
2
CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry.CL-385319 通过阻断病毒进入来抑制 H5N1 禽流感病毒感染。
Eur J Pharmacol. 2011 Jun 25;660(2-3):460-7. doi: 10.1016/j.ejphar.2011.04.013. Epub 2011 Apr 22.
3
Novel trivalent anti-influenza reagent.新型三价抗流感试剂。
流感病毒进入抑制剂
Adv Exp Med Biol. 2022;1366:123-135. doi: 10.1007/978-981-16-8702-0_8.
4
Discovery of New Ginsenol-Like Compounds with High Antiviral Activity.发现具有高抗病毒活性的新人参二醇类化合物。
Molecules. 2021 Nov 10;26(22):6794. doi: 10.3390/molecules26226794.
5
Aryl Sulfonamide Inhibits Entry and Replication of Diverse Influenza Viruses via the Hemagglutinin Protein.芳基磺胺类药物通过血凝素蛋白抑制多种流感病毒的进入和复制。
J Med Chem. 2021 Aug 12;64(15):10951-10966. doi: 10.1021/acs.jmedchem.1c00304. Epub 2021 Jul 14.
6
Macrolactin A as a Novel Inhibitory Agent for SARS-CoV-2 M: Bioinformatics Approach.大环内酯素 A 作为新型 SARS-CoV-2 M 抑制剂:生物信息学方法。
Appl Biochem Biotechnol. 2021 Oct;193(10):3371-3394. doi: 10.1007/s12010-021-03608-7. Epub 2021 Jul 1.
7
C4b Binding Protein Acts as an Innate Immune Effector Against Influenza A Virus.C4 结合蛋白作为抗甲型流感病毒的固有免疫效应因子。
Front Immunol. 2021 Jan 8;11:585361. doi: 10.3389/fimmu.2020.585361. eCollection 2020.
8
Complement-Independent Modulation of Influenza A Virus Infection by Factor H.补体非依赖性调控因子 H 对甲型流感病毒感染的作用
Front Immunol. 2020 Mar 25;11:355. doi: 10.3389/fimmu.2020.00355. eCollection 2020.
9
Insights into structural and inhibitory mechanisms of low pH-induced conformational change of influenza HA2 protein: a computational approach.流感HA2蛋白低pH诱导构象变化的结构与抑制机制洞察:一种计算方法
J Mol Model. 2019 Mar 23;25(4):99. doi: 10.1007/s00894-019-3982-y.
10
A modular synthesis of tetracyclic meroterpenoid antibiotics.四环倍半萜类杂萜抗生素的模块化合成。
Nat Commun. 2017 Dec 12;8(1):2083. doi: 10.1038/s41467-017-02061-7.
Bioorg Med Chem Lett. 2010 Jun 15;20(12):3772-6. doi: 10.1016/j.bmcl.2010.04.060. Epub 2010 Apr 18.
4
Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin.新型流感病毒融合抑制剂:结构-活性关系及与病毒血凝素的相互作用。
J Virol. 2010 May;84(9):4277-88. doi: 10.1128/JVI.02325-09. Epub 2010 Feb 24.
5
Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model.高致病性H5N1流感病毒对神经氨酸酶抑制剂奥司他韦的敏感性在体外和小鼠模型中有所不同。
Antimicrob Agents Chemother. 2009 Jul;53(7):3088-96. doi: 10.1128/AAC.01667-08. Epub 2009 Apr 6.
6
Factors responsible for plaque formation of A/duck/Siberia/272/1998 (H13N6) influenza virus on MDCK cells.1998年从西伯利亚野鸭中分离的A/duck/Siberia/272/1998(H13N6)流感病毒在MDCK细胞上形成斑块的相关因素。
Virus Res. 2009 Mar;140(1-2):194-8. doi: 10.1016/j.virusres.2008.12.005. Epub 2009 Jan 13.
7
PB2 protein of a highly pathogenic avian influenza virus strain A/chicken/Yamaguchi/7/2004 (H5N1) determines its replication potential in pigs.高致病性禽流感病毒A/鸡/山口/7/2004(H5N1)株的PB2蛋白决定其在猪体内的复制潜力。
J Virol. 2009 Feb;83(4):1572-8. doi: 10.1128/JVI.01879-08. Epub 2008 Dec 3.
8
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion.与膜融合抑制剂复合的流感血凝素结构
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17736-41. doi: 10.1073/pnas.0807142105. Epub 2008 Nov 12.
9
Histidine protonation and the activation of viral fusion proteins.组氨酸质子化与病毒融合蛋白的激活
Biochem Soc Trans. 2008 Feb;36(Pt 1):43-5. doi: 10.1042/BST0360043.
10
Medical management of influenza infection.流感感染的医学管理。
Annu Rev Med. 2008;59:397-413. doi: 10.1146/annurev.med.59.061506.213121.